Diagnostic system for detecting breast cancer
| Diagnostic system for detecting breast cancer | |
|---|---|
| Duration 21/07/2008 - 21/07/2011 |
|
| Scope Commercialisation Project |
|
| Summary The aplication of gold nanoparticles to the commercially available ELISA test for CA15-3 antigen, an important biomarker for the medical treatment of breast cancer. |
|
| More Information The goal is to develop a simple, miniaturised and low cost system for the determination of proteins, based on the use of gold nanoparticles as brand and final electrochemical detection, using bionanosensors technology. The studied protein is CA-15-3, which presence in blood is indicative of a possible breast cancer. Rapid and sensitive detection of this protein would allow early diagnosis of the disease, advancing the deadline of patient’s treatment and save lives. The main advantage of the proposed system, compared with traditional systems such as ELISA essays, lies in its speed simplicity and low cost, result of recent advances in nanoscience and nanothechnology. It will be easy to use even for inexperienced people (family doctors and even patients themselves, in the same manner as with glucose sensors), thus contributing to a breakthrough in the fight against this disease. |
|
| ICN Groups Participating in the Project |
|
| ICN Contact Prof. Dr. Arben Merkoçi Hyka |
|
Acknowledgements/Sponsors
|
|
